High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 133, Issue 2, 2006, Pages 173-175

  Milligan, Donald W ^a   Kochethu, Geothy ^a   Dearden, Claire ^b   Matutes, Estella ^b   MacConkey, Christopher ^c   Catovsky, Daniel ^b  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Autologous stem cell transplantation; Chronic lymphocytic leukaemia; Secondary leukaemia and myelodysplasia

Indexed keywords

ALEMTUZUMAB; ANTIINFECTIVE AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE PHOSPHATE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOGRAFT; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONFIDENCE INTERVAL; DYSPLASIA; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; RISK FACTOR; UNITED KINGDOM;

ACUTE DISEASE; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; TRANSPLANTATION CONDITIONING; VIDARABINE PHOSPHATE;

EID: 33645085041     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.05982.x     Document Type: Article

References (13)

1. Aviv H. Tang D. Das K. Harrison J.S. Hameed M. Varma M. 2004 Simultaneous appearance of trisomy 8 and trisomy 12 in different cell populations in a patient with untreated B-cell chronic lymphocytic leukemia and myelodysplasia Leukemia & Lymphoma 45 1279 1283
2. Catovsky D. Fooks J. Richards S. 1989 Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults British Journal of Haematology 72 141 149
3. Gribben J.G. Zahrieh D. Stephans K. Bartlett-Pandite L. Alyea E.P. Fisher D.C. Freedman A.S. Mauch P. Schlossman R. Sequist L.V. Soiffer R.J. Marshall B. Neuberg D. Ritz J. Nadler L.M. 2005 Autologous and allogeneic stem cell transplantation for poor risk chronic lymphocytic leukemia Blood 106 4389 4396
4. Haas R. Moos M. Karcher A. Mohle R. Witt B. Goldschmidt H. Fruhauf S. Flentje M. Wannenmacher M. Hunstein W. 1994 Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma Journal of Clinical Oncology 12 1685 1692
5. Hennessy B.J. Ryley S. Kasprzyk A. Reid C.D. 2000 Malignancy: case report: myelodysplasia following treatment of chronic lymphocytic leukaemia with fludarabine Hematology 4 495 497
6. Krishnan A. Bhatia S. Slovak M.L. Arber D.A. Niland J.C. Nademanee A. Fung H. Bhatia R. Kashyap A. Molina A. O'Donnell M.R. Parker P.A. Sniecinski I. Snyder D.S. Spielberger R. Stein A. Forman S.J. 2000 Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors Blood 95 1588 1593
7. Kumar L. 1995 Secondary leukaemia after autologous bone marrow transplantation Lancet 345 810
8. McLaughlin P. Estey E. Glassman A. Romaguera J. Samaniego F. Ayala A. Hayes K. Maddox A.M. Preti H.A. Hagemeister F.B. 2005 Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha Blood 105 4573 4575
9. Micallef I.N. Lillington D.M. Apostolidis J. Amess J.A. Neat M. Matthews J. Clark T. Foran J.M. Salam A. Lister T.A. Rohatiner A.Z. 2000 Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies Journal of Clinical Oncology 18 947 955
10. Milligan D.W. Fernandes S. Dasgupta R. Davies F.E. Matutes E. Fegan C.D. McConkey C. Child J.A. Cunningham D. Morgan G.J. Catovsky D. 2005 Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses Blood 105 397 404
11. Morrison V.A. Rai K.R. Peterson B.L. Kolitz J.E. Elias L. Appelbaum F.R. Hines J.D. Shepherd L. Larson R.A. Schiffer C.A. 2002 Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011 Journal of Clinical Oncology 20 3878 3884
12. Rabinowe S.N. Soiffer R.J. Gribben J.G. Daley H. Freedman A.S. Daley J. Pesek K. Neuberg D. Pinkus G. Leavitt P.R. 1993 Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia Blood 82 1366 1376
13. Rai K.R. Peterson B.L. Appelbaum F.R. Kolitz J. Elias L. Shepherd L. Hines J. Threatte G.A. Larson R.A. Cheson B.D. Schiffer C.A. 2000 Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia New England Journal of Medicine 343 1750 1757